Castle Biosciences Inc Sustainability Reports

Castle Biosciences Inc. develops and commercializes diagnostic and prognostic tests for dermatologic and gastroenterological cancers. The company provides personalized, clinically actionable genomic solutions to guide patient care and improve disease management.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

LEI: 2549007M2Q4HLR1XD252

FIGI: BBG006YWVSS2

6 reports from 2021 to 2025

• Castle Biosciences Inc 2025 Annual Report
• Castle Biosciences Inc 2024 Environmental, Social & Governance (ESG) Highlights
• Castle Biosciences Inc 2024 Annual Report
• Castle Biosciences Inc 2023 Annual Report
• Castle Biosciences Inc 2022 Annual Report